Archive 20.03.2018

Assistive devices may soon allow people to perform virtually superhuman feats. According to Robert Riener, however, there are more pressing goals than developing superhumans.

Known mostly for their smart warfare systems - Milrem Robotics - is entering the commercial market with its firefighting and search and rescue unmanned ground vehicle being developed together with rescue services.

A pair of autonomous robots developed by Carnegie Mellon University's Robotics Institute will soon be driving through miles of pipes at the U.S. Department of Energy's former uranium enrichment plant in Piketon, Ohio, to identify uranium deposits on pipe walls.

Are we bumping up against the "Robocalypse," when automation sweeps industry and replaces human workers with machines? BU economist Pascual Restrepo says that interpretation is too gloomy, although his recent research, posted online by the National Bureau of Economic Research, reveals that the adoption of just one industrial robot eliminates nearly six jobs in a community.

As a teenager working for his dad's construction business, Noah Ready-Campbell dreamed that robots could take over the dirty, tedious parts of his job, such as digging and leveling soil for building projects.

In this episode, Audrow Nash speaks with Maja Matarić, a professor at the University of Southern California and the Chief Scientific Officer of Embodied, about socially assistive robotics. Socially assistive robotics aims to endow robots with the ability to help people through individual non-contact assistance in convalescence, rehabilitation, training, and education. For example, a robot could help a child on the autism spectrum to connect to more neurotypical children and could help to motivate a stroke victim to follow their exercise routine for rehabilitation (see the videos below). In this interview, Matarić discusses the care gap in health care, how her work leverages research in psychology to make robots engaging, and opportunities in socially assistive robotics for entrepreneurship.

A short video about how personalized robots might act as a “social bridge” between a child on the autism spectrum and a more neurotypical child.

 

A short video about how a robot could assist stroke victims in their recovery.

 

Maja Matarić

Maja Matarić is professor and Chan Soon-Shiong chair in Computer Science Department, Neuroscience Program, and the Department of Pediatrics at the University of Southern California, founding director of the USC Robotics and Autonomous Systems Center (RASC), co-director of the USC Robotics Research Lab and Vice Dean for Research in the USC Viterbi School of Engineering. She received her PhD in Computer Science and Artificial Intelligence from MIT, MS in Computer Science from MIT, and BS in Computer Science from the University of Kansas. 

 

 

Links

• Interaction Lab
• Embodied
• Subscribe to Robots using iTunes
• Subscribe to Robots using RSS
• Support us on Patreon
• Download MP3 (13.7 MB)

At South by Southwest, as entrepreneurs and celebrities mingle to discuss the future of tech, a lot of the hype focuses on attention-grabbing projects such as flying cars. But there also are ideas on display with a more practical bent—projects that could get into consumers' hands sooner.

The mission of my lab is to discover new types of materials that will allow machines, robots, and electronics to be more compatible with our everyday environment.

Bellows are most often used to protect critical components. Actuators used in motion control equipment are often exposed to contaminants ranging from dust and abrasive grit to metal chips and weld spatter.

Using an all-terrain wheelchair as a platform, the undergraduates are building a communications network and algorithms for autonomy, navigation, and vision processing as part of a student challenge

A research team of Seoul National University led by Professor Kyu-Jin Cho has developed an origami-inspired robotic arm that is foldable, self-assembling and also highly-rigid. (The researchers include Suk-Jun Kim, Dae-Young Lee, Gwang-Pil Jung, Professor of SeoulTech)

Crimes that involve chemical, biological, radiological or nuclear (CBRN) materials pose a deadly threat not just to the target of the attack but to innocent bystanders and police investigators. Often, these crimes may involve unusual circumstances or they are terrorist-related incidents, such as an assassination attempt or the sending of poisons through the mail.

The European Robotics Forum 2018 (ERF2018), the most influential meeting of the robotics community in Europe, takes place in Tampere on 13-15 March 2018. ERF brings together over 900 leading scientists, companies, and policymakers for the largest robotics networking event in Europe.

Under the theme “Robots and Us”, the over 50 workshops cover current societal and technical themes, including human-robot-collaboration and how robotics can improve industrial productivity and service sector operations.

During the opening the ERF2018, on 13 March, Juha Heikkilä, Head of unit, EC DG CNECT, explained that “the European Robotics Forum has been instrumental in breaking down silos and bringing together a strong, integrated robotics community in Europe. This year’s theme, “Robots and Us”, reflects the increasingly broad impact of robotics and allows discussing not just technology but also the all-important non-technological aspects of robotics.”

Anne Berner, Minister of Transport and Communications of Finland, emphasized in her keynote that “digitalization and robotics require changes in mindset from both the public and the private sector in Finland. We, as the public side, create a framework for change, but the responsibility for implementing lies with companies. Robotics and automation walk on the road paved with data. Data that is not shared is benefitting no one. Data needs to be combined with other data and then refined and enriched with knowledge to create value”.

Tomas Hedenborg, President of Orgalime and Group CEO of Fastems, added that “in the era of digitalization, automation and more specifically robotization, is in the core of the transformation. The huge innovation potential includes major societal challenges that need to be tackled in parallel.” 

The end of the Opening saw a panel discussion about “How should the society prepare for the rapid development of robotics” with the keynote speakers and representatives of the local organisers.

Photo, from left to right: Tomas Hedenborg, Orgalime/Fastems; Marketta Niemelä, VTT; Minna Lanz, Tampere University of Technology; Jyrki Kasvi, Finish MP; Bernd Liepert, euRobotics/KUKA; Thomas Pilz, Pilz; Juha Heikkilä, EC

The conference showcases the newest research in the field, and the projects funded under EU’s Horizon 2020 research programme. By bringing together over 50 sponsors and exhibitors, amongst them Fastems, KUKA and Sandvik (Platinum sponsors) and Schunk (Gold sponsor), the event offers a unique window to the European robotics, also putting the spotlight on the Nordic markets.

ERF2018 had the honour to welcome Markku Markkula, First Vice-President of the European Committee of the Regions, who visited the exhibition area and gave a speech at the reception hosted by the Tampere City Hall.

Photo from left to right: Anna-Kaisa Heinämäki, Deputy Mayor of City of Tampere; Bernd Liepert, President of euRobotics; Reinhard Lafrenz, euRobotics Secretary General; Jyrki Latokartano from The Robotics Society in Finland; Markku Markkula, First Vice-President of the European Committee of the Regions

The Awards Ceremony on 14 March will announce the winners of the Georges Giralt PhD Award 2017 and 2018, the TechTransfer Award 2018 and the European Robotics League Service and Emergency Robots Season 2017-2018.

After its start in San Sebastian in 2010, The European Robotics Forums has grown into a major annual event with hundreds of attendees every year. In 2017, the conference was held in Edinburgh.

The European Robotics Forum is organised by euRobotics under SPARC, the Public-Private partnership for Robotics in Europe.  ERF2018 is hosted by The Robotics Society in Finland in collaboration with Tampere University of Technology.

By Rob Matheson

If you’re a rock climber, hiker, runner, dancer, or anyone who likes recording themselves while in motion, a personal drone companion can now do all the filming for you — completely autonomously.

Skydio, a San Francisco-based startup founded by three MIT alumni, is commercializing an autonomous video-capturing drone — dubbed by some as the “selfie drone” — that tracks and films a subject, while freely navigating any environment.

Called R1, the drone is equipped with 13 cameras that capture omnidirectional video. It launches and lands through an app — or by itself. On the app, the R1 can also be preset to certain filming and flying conditions or be controlled manually.

The concept for the R1 started taking shape almost a decade ago at MIT, where the co-founders — Adam Bry SM ’12, Abraham Bacharach PhD ’12, and Matt Donahoe SM ’11 — first met and worked on advanced, prize-winning autonomous drones. Skydio launched in 2014 and is releasing the R1 to consumers this week.

“Our goal with our first product is to deliver on the promise of an autonomous flying camera that understands where you are, understands the scene around it, and can move itself to capture amazing video you wouldn’t otherwise be able to get,” says Bry, co-founder and CEO of Skydio.

Deep understanding

Existing drones, Bry says, generally require a human pilot. Some offer pilot-assist features that aid the human controller. But that’s the equivalent of having a car with adaptive cruise control — which automatically adjusts vehicle speed to maintain a safe distance from the cars ahead, Bry says. Skydio, on the other hand, “is like a driverless car with level-four autonomy,” he says, referring to the second-highest level of vehicle automation.

R1’s system integrates advanced algorithm components spanning perception, planning, and control, which give it unique intelligence “that’s analogous to how a person would navigate an environment,” Bry says.

On the perception side, the system uses computer vision to determine the location of objects. Using a deep neural network, it compiles information on each object and identifies each individual by, say, clothing and size. “For each person it sees, it builds up a unique visual identification to tell people apart and stays focused on the right person,” Bry says.

That data feeds into a motion-planning system, which pinpoints a subject’s location and predicts their next move. It also recognizes maneuvering limits in one area to optimize filming. “All information is constantly traded off and balanced … to capture a smooth video,” Bry says.

Finally, the control system takes all information to execute the drone’s plan in real time. “No other system has this depth of understanding,” Bry says. Others may have one or two components, “but none has a full, end-to-end, autonomous [software] stack designed and integrated together.”

For users, the end result, Bry says, is a drone that’s as simple to use as a camera app: “If you’re comfortable taking pictures with your iPhone, you should be comfortable using R1 to capture video.”

A user places the drone on the ground or in their hand, and swipes up on the Skydio app. (A manual control option is also available.) The R1 lifts off, identifies the user, and begins recording and tracking. From there, it operates completely autonomously, staying anywhere from 10 feet to 30 feet away from a subject, autonomously, or 300 feet away, manually, depending on Wi-Fi availability.

When batteries run low, the app alerts the user. Should the user not respond, the drone will find a flat place to land itself. After the flight — which can last about 16 minutes, depending on speed and use — users can store captured video or upload it to social media.

Through the app, users can also switch between several cinematic modes. For instance, with “stadium mode,” for field sports, the drone stays above and moves around the action, following selected subjects. Users can also direct the drone where to fly (in front, to the side, or constantly orbiting). “These are areas we’re now working on to add more capabilities,” Bry says.

The lightweight drone can fit into an average backpack and runs about $2,500.

Skydio takes wing

Bry came to MIT in 2009, “when it was first possible to take a [hobby] airplane and put super powerful computers and sensors on it,” he says.

He joined the Robust Robotics Group, led by Nick Roy, an expert in drone autonomy. There, he met Bacharach, now Skydio’s chief technology officer, who that year was on a team that won the Association for Unmanned Vehicles International contest with an autonomous minihelicopter that navigated the aftermath of a mock nuclear meltdown. Donahoe was a friend and graduate student at the MIT Media Lab at the time.

In 2012, Bry and Bacharach helped develop autonomous-control algorithms that could calculate a plane’s trajectory and determine its “state” — its location, physical orientation, velocity, and acceleration. In a series of test flights, a drone running their algorithms maneuvered around pillars in the parking garage under MIT’s Stata Center and through the Johnson Athletic Center.

These experiences were the seeds of Skydio, Bry says: “The foundation of the [Skydio] technology, and how all the technology works and the recipe for how all of it comes together, all started at MIT.”

After graduation, in 2012, Bry and Bacharach took jobs in industry, landing at Google’s Project Wing delivery-drone initiative — a couple years before Roy was tapped by Google to helm the project. Seeing a need for autonomy in drones, in 2014, Bry, Bacharach, and Donahoe founded Skydio to fulfill a vision that “drones [can have] enormous potential across industries and applications,” Bry says.

For the first year, the three co-founders worked out of Bacharach’s dad’s basement, getting “free rent in exchange for helping out with yard work,” Bry says. Working with off-the-shelf hardware, the team built a “pretty ugly” prototype. “We started with a [quadcopter] frame and put a media center computer on it and a USB camera. Duct tape was holding everything together,” Bry says.

But that prototype landed the startup a seed round of $3 million in 2015. Additional funding rounds over the next few years — more than $70 million in total — helped the startup hire engineers from MIT, Google, Apple, Tesla, and other top tech firms.

Over the years, the startup refined the drone and tested it in countries around the world — experimenting with high and low altitudes, heavy snow, fast winds, and extreme high and low temperatures. “We’ve really tried to bang on the system pretty hard to validate it,” Bry says.

Athletes, artists, inspections

Early buyers of Skydio’s first product are primarily athletes and outdoor enthusiasts who record races, training, or performances. For instance, Skydio has worked with Mikel Thomas, Olympic hurdler from Trinidad and Tobago, who used the R1 to analyze his form.

Artists, however, are also interested, Bry adds: “There’s a creative element to it. We’ve had people make music videos. It was themselves in a driveway or forest. They dance and move around and the camera will respond to them and create cool content that would otherwise be impossible to get.”

In the future, Skydio hopes to find other applications, such as inspecting commercial real estate, power lines, and energy infrastructure for damage. “People have talked about using drones for these things, but they have to be manually flown and it’s not scalable or reliable,” Bry says. “We’re going in the direction of sleek, birdlike devices that are quiet, reliable, and intelligent, and that people are comfortable using on a daily basis.”

It was the last question of the night and it hushed the entire room. An entrepreneur expressed his aggravation about the FDA’s antiquated regulatory environment for AI-enabled devices to Dr. Joel Stein of Columbia University. Stein a leader in rehabilitative robotic medicine, sympathized with the startup knowing full well that tomorrow’s exoskeletons will rely heavily on machine intelligence. Nodding her head in agreement, Kate Merton of JLabs shared the sentiment. Her employer, Johnson & Johnson, is partnered with Google to revolutionize the operating room through embedded deep learning systems. In many ways this astute observation encapsulated RobotLab this past Tuesday with our topic being “The Future Of Robotic Medicine,” the paradox of software-enabled therapeutics offering a better quality of life and the societal, technological and regulatory challenges ahead.

To better understand the frustration expressed at RobotLab, a review of the policies of the Food & Drug Administration (FDA) relative to medical devices and software is required. Most devices fall within a criteria that was established in the 1970s. The “build and freeze” model whereby a product filed doesn’t change overtime and currently excludes therapies that rely on neural networks and deep learning algorithms that evolve with use. Charged with progressing its regulatory environment, the Obama Administration established a Digital Health Program tasked with implementing new regulatory guidance for software and mobile technology. This initiative eventually led Congress to pass the 21st Century Cures Act (“Cures Act”) in December 2016. An important aspect of the Cures Act is its provisions for digital health products, medical software, and smart devices. The legislators singled out AI for its unparalleled ability to be used in supporting human decision making referred to as “Clinical Decision Support” (“CDS”) with examples like Google and IBM Watson. Last year, the administration updated the Cures Act with a new framework that included a Digital Health Innovation Action Plan. These steps have been leading a change in the the FDA’s attitude towards mechatronics, updating its traditional approach to devices to include software and hardware that iterates with cognitive learning. The Action Plan states “an efficient, risk-based approach to regulating digital health technology will foster innovation of digital health products.” In addition, the FDA has been offering tech partners the ability of filing a Digital Health Software Pre-Certification (“Pre-Cert”) to fast track the evaluation and approval process, current Pre-Cert pilot filings include Apple, Fitbit, Samsung and other leading technology companies.

Another way for AI and robotic devices to receive approval from the FDA is through their “De Novo premarket review pathway.” According to the FDA’s website, the De Novo program is designed for “medical devices that are low to moderate risk and have no legally marketed predicate device to base a determination of substantial equivalence.” Many computer vision systems fall into the De Novo category using their sensors to provide “triage” software to efficiently identify disease markers based upon its training data of radiology images. As an example, last month the FDA approved Viz.ai a new type of “clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients.”

Dr. Robert Ochs of the FDA’s Center for Devices and Radiological Health explains, “The software device could benefit patients by notifying a specialist earlier thereby decreasing the time to treatment. Faster treatment may lessen the extent or progression of a stroke.” The Viz.ai algorithm has the ability to change the lives of the nearly 800,000 annual stroke victims in the USA. The data platform will enable clinicians to quickly identify patients at risk for stroke by analyzing thousands of CT brain scans for blood vessel blockages and then automatically send alerts via text messages to neurovascular specialists. Viz.AI promises to streamline the diagnosis process by cutting the traditional time it takes for radiologists to review, identify and escalate cases to specialists for high-risk patients.

Dr. Chris Mansi, Viz.ai CEO, says “The Viz.ai LVO Stroke Platform is the first example of applied artificial intelligence software that seeks to augment the diagnostic and treatment pathway of critically unwell stroke patients. We are thrilled to bring artificial intelligence to healthcare in a way that works alongside physicians and helps get the right patient, to the right doctor at the right time.” According to the FDA’s statement, Mansi’s company “submitted a study of only 300 CT scans that assessed the independent performance of the image analysis algorithm and notification functionality of the Viz.ai Contact application against the performance of two trained neuro-radiologists for the detection of large vessel blockages in the brain. Real-world evidence was used with a clinical study to demonstrate that the application could notify a neurovascular specialist sooner in cases where a blockage was suspected.”

Viz.ai joins a market for AI diagnosis software that is growing rapidly and projected to eclipse six billion by 2021 (Frost & Sullivan), an increase of more than forty percent since 2014. According to the study, AI has the ability to reduce healthcare costs by nearly half, while at the same time improving the outcomes for a third of all US healthcare patients. However, diagnosis software is only part of the AI value proposition, adding learning algorithms throughout the entire ecosystem of healthcare could provide new levels of quality of care.

At the same time, the demand for AI treatment is taking its toll on an underfunded FDA which is having difficulty keeping up with the new filings to review computer-aided therapies from diagnosis to robotic surgery to invasive therapeutics. In addition, many companies are currently unable to afford the seven-figure investment required to file with the FDA, leading to missed opportunities to find cures for the most plaguing diseases. The Atlantic reported last fall about a Canadian company, Cloud DX, that is still waiting for approval for its AI software that analyzes coughing data via audio wavelengths to detect lung-based diseases (i.e., asthma, tuberculosis, and pneumonia). Cloud DX’s founder, Robert Kaul, shared wth the magazine, “There’s a reason that tech companies like Google haven’t been going the FDA route [of clinical trials aimed at diagnostic certification]. It can be a bureaucratic nightmare, and they aren’t used to working at this level of scrutiny and slowness.” It took Cloud DX two years and close to a million dollars to achieve the basic ISO 13485 certification required to begin filing with the agency. Kaul, questioned, “How many investors are going to give you that amount of money just so you can get to the starting line?”

Last month, Rani Therapeutics raised $53 million to begin clinical trials for its new robotic pill. Rani’s solution could usher in a new paradigm of needle-free therapy, whereby drugs are mechanically delivered to the exact site of infection. Unfortunately, innovations like Rani’s are getting backlogged with a shortage of knowledgable examiners able review the clinical data. Bakul Patel, the FDA’s New Associate Center Director For Digital Health, describes that one of his top priorities is hiring, “Yes, it’s hard to recruit people in AI right now. We have some understanding of these technologies. But we need more people. This is going to be a challenge.” Patel is cautiously optimistic, “We are evolving… The legacy model is the one we know works. But the model that works continuously—we don’t yet have something to validate that. So the question is [as much] scientific as regulatory: How do you reconcile real-time learning [with] people having the same level of trust and confidence they had yesterday?”

As I concluded my discussion with Stein, I asked if he thought disabled people will eventually be commuting to work wearing robotic exoskeletons as easily as they do in electric wheelchairs? He answered that it could come within the next decade if society changes its mindset on how we distribute and pay for such therapies. To quote the President, “Nobody knew health care could be so complicated.”